M.V. Investments: What Really Changes in the Move From Series A to Series E
The March 2026 refinancing thread does not deleverage the company and does not free collateral. It replaces Series A with a longer series on the same assets, with more collateral flexibility and a different covenant package.
The main article argued that the portfolio got bigger, but the real bottleneck was still funding. The March 2026 thread shows how the company is trying to address exactly that bottleneck, not by freeing assets or genuinely shrinking debt, but by replacing Series A with Series E on the same two Tel Aviv properties.
For a bond-only issuer, that is not a technical detail. It is the story. When there is no listed equity instrument at the center, the maturity map, the collateral structure, and the covenant package are the best way to judge whether the company bought real time or merely moved the pressure into a later window.
The core point: this is liability recycling, not deleveraging. Series A had NIS 74.5 million of principal outstanding at the end of 2025, but the conditional early redemption already requires NIS 84.3 million. Series E is therefore meant to refinance not only principal, but also accrued interest, CPI linkage, and the early-redemption premium. The pressure is pushed forward, not erased.
The Maturity Schedule Moves, The Debt Does Not Disappear
The immediate benefit is clear. Series A was still scheduled to amortize in June 2026, June 2027, and June 2028, with 70% of the principal still sitting at the back end. The Series E draft pushes principal repayment out to March 2029, March 2030, and March 2031. That buys room, especially across 2026 to 2028.
But this is not a repayment from internal liquidity. The early-redemption report sets a very clear condition: to take out Series A, the company must complete a Series E issuance of at least NIS 84.343883 million par value. Because the new bonds are to be offered at par, the company is effectively replacing NIS 74.545 million of Series A principal with a new series whose minimum size is already almost NIS 9.8 million larger. That difference is the refinancing cost, not excess cash.
This also will not pass quietly through the next set of numbers. The company already stated that the early redemption is expected to create a loss of roughly NIS 6.6 million. That matters. Part of the refinancing cost will hit earnings immediately, even before the market knows the final coupon on Series E.
That is why the move looks better on the maturity ladder than on the leverage line. The amortization is pushed out, but nominal debt does not contract. At the minimum size, it actually rises. If the final coupon comes in high, part of the duration relief may be purchased at a materially heavier running cost.
The Collateral Is Not Released, It Is Recycled
Anyone looking for Idelson 17 and Nahmani 64 to come out of the financing structure will not get that. Series A is already secured by first-ranking liens on those two assets, and the Series E draft says those same assets will be pledged again for the new holders. The company is not extracting collateral from the structure. It is reusing it.
The more important point is not only what is pledged, but how that collateral can be used after the swap. Under the Series E draft, the proceeds are not meant to fall straight into the company's unrestricted cash box. Before the proceeds are released, except for the portion used to repay Series A obligations, first-ranking liens on Idelson and Nahmani must be registered. That reinforces the reading that this is first and foremost a closed-loop refinancing event, and only after that a possible source of additional flexibility.
From there, Series E is built as a more flexible financing instrument. The draft allows the company to replace pledged assets, sell apartments or parts of pledged assets, and release excess proceeds from the trust account, as long as debt-to-collateral stays at or below 75% at the relevant test points. On top of that, the company can enlarge the series without holder approval, provided it remains in compliance, keeps post-expansion debt-to-collateral at or below 75%, and does not exceed NIS 180 million par value in total.
That is the heart of it. The move from Series A to Series E does not free the cushion. It turns that cushion from a relatively closed refinancing anchor into a reusable funding platform that can be expanded, managed, and monetized through asset mechanics, as long as the collateral math holds. For the company that is flexibility. For bondholders it is also a reason to watch how quickly that room gets consumed.
The Covenant Package Changes, Not in One Direction
The comparison between Series A and Series E is interesting precisely because it does not move in a single direction. The corporate-level floor becomes tighter, while the collateral test becomes looser.
| Parameter | Series A | Series E draft | Analytical read |
|---|---|---|---|
| Size relevant to the move | NIS 74.545m principal outstanding | Minimum issuance of NIS 84.344m par value | This is a costlier refinancing, not debt retirement |
| Principal schedule | 10% in June 2026, 10% in June 2027, 70% in June 2028 | 5% in March 2029, 5% in March 2030, 90% in March 2031 | Clear back-end extension |
| Collateral | Idelson 17 and Nahmani 64 | The same assets, re-pledged on a first-ranking basis | No asset release, only collateral recycling |
| Minimum equity | NIS 50m | NIS 130m | Higher corporate floor |
| Equity-to-balance-sheet ratio | 22% | 22% | This test does not move |
| Debt-to-collateral cap | Up to 75% | Up to 85% | More leverage room on the same collateral |
| Maximum coupon step-up | Up to 1.2% | Up to 1.5% | A breach becomes more expensive |
On paper, Series E looks tighter because the minimum equity threshold jumps to NIS 130 million. In practice, at the end of 2025 the company was already at NIS 281.3 million of equity and a 39.35% equity-to-balance-sheet ratio. So the live bottleneck is not the corporate equity floor. The live issue is the collateral test, and that is exactly where Series E widens the ceiling from 75% to 85%.
That is a material shift. The company is asking the market to replace a shorter series with more conservative collateral coverage by a longer series that gives the same collateral more working room. That is not automatically a bad deal for bondholders, but it needs to be read correctly: the tighter part sits in the equity floor and distribution framework, while the looser part sits where the collateral can carry more debt.
The distribution restrictions in Series E make that tradeoff even clearer. The company may distribute only if the post-distribution equity-to-balance-sheet ratio remains at least 30%, equity stays above NIS 180 million, and the distribution does not exceed 30% of annual net income after excluding unrealized fair-value gains. In the annual Series A summary, the disclosure points readers back to the trust deed for distribution restrictions. In the Series E draft, that framework is put front and center. For holders, that is part of the price the company pays for asking for more room on the collateral side.
What This Means for the Funding Map
The move solves one problem, but only one problem. It takes the Idelson-Nahmani leg out of the 2026 to 2028 window, but it does not answer the funding question for the rest of the bond stack. So Series E should not be read as proof that the company has exited the refinancing loop. It should be read as the replacement of one short secured leg with a longer and more flexible one.
What the market needs to measure now is not the intention to refinance, but its price. The coupon on Series E is still not fixed. If the final coupon lands at a reasonable level, the company truly buys time against the same assets. If the coupon lands high, or if the series is expanded too quickly after issuance, the reading changes. At that point it would look less like a cleaner maturity ladder and more like a new debt channel built on the same collateral cushion.
Bottom line: March 2026 changes M.V. Investments' debt map, but not in the direction of deleveraging. The short Series A, secured by Idelson and Nahmani, is meant to disappear, and Series E is meant to replace it with a longer instrument on the same assets, with more collateral flexibility and a higher equity floor. The key question now is not whether the refinancing will happen, but what kind of refinancing it becomes: a sensible deferral of pressure, or one more layer of debt that keeps the same assets fully occupied for years.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.